Evidence map›Paper›PMID 21045240›Full record

ReviewMolecular interventions2010

Fractalkine/CX3CL1: a potential new target for inflammatory diseases.

Brian A Jones, Maria Beamer, Salahuddin Ahmed

Abstract readReview
In one paragraph

Review in Molecular interventions, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed.

  1. Intake ofNutrients · 2023
    Trial
  2. Trial
  3. The CX3CL1-CX3CR1 axis in HIV-associated inflammation and cardiometabolic disease.American journal of physiology. Regulatory, integrative and comparative physiology · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Injury to repair: Functions of microglia and monocyte-derived cells in ischemic stroke.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Brian A JonesDepartment of Pharmacology, College of Pharmacy, University of Toledo, OH, USA.
Maria Beamer
Salahuddin Ahmed

Funding

Inhibition of RA synovial fibroblasts invasion by green tea polyphenolsR21AT003633 · NCCIH · UNIVERSITY OF TOLEDO · PI AHMED, SALAH-UDDIN · 2007 to 2008
$376k
Inhibition of CCR1/CCR5 mediated angiogenesis and joint destruction by EGCGR03AR055741 · NIAMS · UNIVERSITY OF TOLEDO · PI AHMED, SALAH-UDDIN · 2008 to 2010
$223k
NCCIH NIH HHS AT-003633NCCIH NIH HHS R21 AT003633NIAMS NIH HHS AR-055741NIAMS NIH HHS R03 AR055741
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnti-Inflammatory AgentsChemokine CX3CL1HumansInflammationModels, BiologicalModels, MolecularAnti-Inflammatory AgentsChemokine CX3CL1

Identifiers

PMID21045240
PMCPMC3002219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.